ObsEva SA (NASDAQ:OBSV – Get Free Report) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. ObsEva shares last traded at $0.00, with a volume of 32,006 shares.
ObsEva Stock Down 100.0%
The company has a market cap of $7.94 million, a PE ratio of 0.00 and a beta of 0.68.
About ObsEva
ObsEva SA is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, that focuses on developing novel treatments for women’s reproductive health and pregnancy-related disorders. Founded in 2012, the company seeks to address significant unmet medical needs in areas such as endometriosis, preterm labor and embryo implantation support. ObsEva’s research platform is built around small‐molecule modulators of hormones and receptors involved in reproductive physiology.
The company’s most advanced programs include nolasiban (OBE001), an oral oxytocin receptor antagonist designed to improve implantation rates in in vitro fertilization (IVF) procedures; OBE2109, an orally available GnRH antagonist targeting pain and inflammation associated with endometriosis; and OBE022, a selective prostaglandin F2α receptor antagonist for the prevention of preterm labor.
Further Reading
- Five stocks we like better than ObsEva
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.
